Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as “Shanghai Pharmaceuticals” or the “Company”) is a large pharmaceutical industry group listed in Shanghai and Hong Kong (HKEx stock code: 02607; Shanghai Stock Exchange stock code: 601607). The company’s registered capital is 3.696 billion yuan. Its main business covers the pharmaceutical industry and commerce. Its operating income in 2022 is 232 billion yuan. It ranks among the Fortune Global 500 and the top 50 global pharmaceutical companies. Its comprehensive strength ranks among the top three Chinese pharmaceutical companies. It was selected SSE 180 Index, CSI 300 Index constituent stocks, Morgan Stanley China Index (MSCI).

Shanghai Pharmaceuticals advocates the core corporate values ​​of “innovation, integrity, cooperation, tolerance and responsibility”, is committed to perseverance, improves the quality of people’s healthy life, and strives to become a respected and leading brand drug manufacturer with industry reputation and health field. service provider.